Jagsonpal Pharmaceuticals Ltd
Jagsonpal Pharmaceuticals Ltd Share Price Today: Live Updates & Key Insights
Get insights on Jagsonpal Pharmaceuticals Ltd’s fundamentals, financials, shareholding, peer comparison, corporate actions & performance. Track key metrics, price trends & market sentiment for informed decisions. Explore all data at Motilal Oswal.
Jagsonpal Pharmaceuticals Ltd Share Price Chart
Jagsonpal Pharmaceuticals Ltd Fundamentals
Traded Volume: 44,994
Market Cap(Cr): 1,346
Avg Traded Price 202.86
1 Year return -14.96%
Upper Circuit 207
Lower Circuit 201.1
P/E TTM 22.00
P/B Ratio 9.00
Traded Value(Cr) 90.70
EPS TTM 9.275
Book value 9.275
Dividend 1.00%
Jagsonpal Pharmaceuticals Ltd Share Price Performance
Shows the percentage change in stock price over different time periods
This section highlights Jagsonpal Pharmaceuticals Ltd stock price performance across key timeframes, including 1-week, 1-month, 3-month, Year-To-Date (YTD), and 1-year returns. It provides insights into the Jagsonpal Pharmaceuticals Ltd share price history, short-term movements, long-term trends, and overall investor sentiment
1W -3.90%
1M -7.21%
3M -17.40%
1Y -14.96%
YTD -20.76%
Jagsonpal Pharmaceuticals Ltd Traded Volume Movement
Shows the trading volume over different time periods
This section highlights Jagsonpal Pharmaceuticals Ltd daily and average traded volumes, offering insights into investor activity and market liquidity. Higher volumes than average often indicate rising interest, news impact, or shifting market sentiment
Yesterday 34317.00
Day Before Yesterday 14664.00
1W Avg 34458.20
1M Avg 59240.67
3M Avg 90641.52
Jagsonpal Pharmaceuticals Ltd Technical Details
Jagsonpal Pharmaceuticals Ltd technical indicators, such as support and resistance levels and pivot points, are calculated based on historical price and volume trends. These metrics help traders anticipate possible price movements and make informed trading decisions.
Support 1 null
Support 2 null
Support 3 null
Pivot Point : null
Resistance 1 null
Resistance 2 null
Resistance 3 null
Jagsonpal Pharmaceuticals Ltd Corporate Actions
Jagsonpal Pharmaceuticals Ltd corporate actions include dividends, bonus issues, stock splits, and key company updates that may affect share price and investor sentiment. This section provides timely details on past and upcoming actions, including ex-date, record date, and payout ratio - helping investors make informed decisions based on Jagsonpal Pharmaceuticals Ltd’s capital allocation strategies.
All
Ex-Date 12-Sep-2025 Type D Description 2.50/share@125.00% Record Date 12-Sep-2025 Ratio 125.00
Ex-Date 08-Jan-2025 Type S Description share@1:2.50 Record Date 08-Jan-2025 Ratio 1:2.50
Ex-Date 06-Sep-2024 Type D Description 5.00/share@100.00% Record Date 06-Sep-2024 Ratio 100.00
Ex-Date 21-Aug-2023 Type D Description 5.00/share@100.00% Record Date 21-Aug-2023 Ratio 100.00
Ex-Date 29-Oct-2021 Type D Description 4.00/share@80.00% Record Date 01-Nov-2021 Ratio 80.00
Ex-Date 22-Sep-2021 Type D Description 1.00/share@20.00% Record Date - Ratio 20.00
Ex-Date 22-Sep-2020 Type D Description 0.50/share@10.00% Record Date - Ratio 10.00
Ex-Date 20-Sep-2019 Type D Description 0.25/share@5.00% Record Date - Ratio 5.00
Ex-Date 18-Sep-2018 Type D Description 0.10/share@2.00% Record Date - Ratio 2.00
Ex-Date 21-Sep-2017 Type D Description 0.10/share@2.00% Record Date - Ratio 2.00
Ex-Date 21-Sep-2016 Type D Description 0.10/share@2.00% Record Date - Ratio 2.00
Ex-Date 21-Sep-2015 Type D Description 0.10/share@2.00% Record Date - Ratio 2.00
Ex-Date 25-Sep-2014 Type D Description 0.50/share@10.00% Record Date - Ratio 10.00
Ex-Date 25-Sep-2013 Type D Description 0.50/share@10.00% Record Date - Ratio 10.00
Ex-Date 21-Sep-2012 Type D Description 5.00/share@10.00% Record Date - Ratio 10.00
Ex-Date 23-Sep-2011 Type D Description 0.50/share@10.00% Record Date - Ratio 10.00
Ex-Date 21-Sep-2010 Type D Description 0.50/share@10.00% Record Date - Ratio 10.00
Ex-Date 23-Sep-2009 Type D Description 0.25/share@5.00% Record Date - Ratio 5.00
Ex-Date 24-Sep-2008 Type D Description 0.10/share@2.00% Record Date - Ratio 2.00
Ex-Date 21-Sep-2007 Type D Description 0.10/share@2.00% Record Date - Ratio 2.00
Dividends
Announcement Date 12-Sep-2025 Ex Dividend Date 12-Sep-2025 Dividend(%) 125
Announcement Date 06-Sep-2024 Ex Dividend Date 06-Sep-2024 Dividend(%) 100
Announcement Date 21-Aug-2023 Ex Dividend Date 21-Aug-2023 Dividend(%) 100
Announcement Date 29-Oct-2021 Ex Dividend Date 29-Oct-2021 Dividend(%) 80
Announcement Date 22-Sep-2021 Ex Dividend Date 22-Sep-2021 Dividend(%) 20
Announcement Date 22-Sep-2020 Ex Dividend Date 22-Sep-2020 Dividend(%) 10
Announcement Date 20-Sep-2019 Ex Dividend Date 20-Sep-2019 Dividend(%) 5
Announcement Date 18-Sep-2018 Ex Dividend Date 18-Sep-2018 Dividend(%) 2
Announcement Date 21-Sep-2017 Ex Dividend Date 21-Sep-2017 Dividend(%) 2
Announcement Date 21-Sep-2016 Ex Dividend Date 21-Sep-2016 Dividend(%) 2
Announcement Date 21-Sep-2015 Ex Dividend Date 21-Sep-2015 Dividend(%) 2
Announcement Date 25-Sep-2014 Ex Dividend Date 25-Sep-2014 Dividend(%) 10
Announcement Date 25-Sep-2013 Ex Dividend Date 25-Sep-2013 Dividend(%) 10
Announcement Date 21-Sep-2012 Ex Dividend Date 21-Sep-2012 Dividend(%) 10
Announcement Date 23-Sep-2011 Ex Dividend Date 23-Sep-2011 Dividend(%) 10
Announcement Date 21-Sep-2010 Ex Dividend Date 21-Sep-2010 Dividend(%) 10
Announcement Date 23-Sep-2009 Ex Dividend Date 23-Sep-2009 Dividend(%) 5
Announcement Date 24-Sep-2008 Ex Dividend Date 24-Sep-2008 Dividend(%) 2
Announcement Date 21-Sep-2007 Ex Dividend Date 21-Sep-2007 Dividend(%) 2
Bonus
No Bonus has been declared by JAGSNPHARM
Splits
Record Date 08-Jan-2025 Split Date 08-Jan-2025 Face Value (Before/After) 5.00/2.00
Others
Rights No Rights has been declared by JAGSNPHARM
Jagsonpal Pharmaceuticals Ltd Peer Comparison
Shows key financial metrics for the company and its peers
This section compares Jagsonpal Pharmaceuticals Ltd with leading peers in the banking sector based on key metrics such as market capitalization, 1-year return, P/E (TTM), and PB ratio. It helps investors evaluate Jagsonpal Pharmaceuticals Ltd's relative performance and valuation against major competitors.
Stock Name Windlas Biotech Ltd ₹794.05 (-1.27%) M. Cap (Cr) 16.74 1 Yr Return (%) -14.31% P/E (TTM) 24.72 PB Ratio 3.53
Stock Name Syncom Formulations (India) Ltd ₹15.87 (-0.81%) M. Cap (Cr) 14.92 1 Yr Return (%) -19.73% P/E (TTM) 23.64 PB Ratio 4.36
Stock Name Hester Biosciences Ltd ₹1671.80 (-1.39%) M. Cap (Cr) 14.22 1 Yr Return (%) -29.81% P/E (TTM) 32.44 PB Ratio 4.53
Stock Name Jagsonpal Pharmaceuticals Ltd ₹201.59 (-2.06%) M. Cap (Cr) 13.46 1 Yr Return (%) -14.96% P/E (TTM) 21.73 PB Ratio 6.83
Stock Name Bajaj Healthcare Ltd ₹425.60 (-1.18%) M. Cap (Cr) 13.44 1 Yr Return (%) +10.76% P/E (TTM) 29.32 PB Ratio 3.02
Stock Name Sigachi Industries Ltd ₹34.63 (-1.81%) M. Cap (Cr) 13.23 1 Yr Return (%) -27.40% P/E (TTM) -24.04 PB Ratio 2.20
Stock Name Lincoln Pharmaceuticals Ltd ₹529.10 (-0.81%) M. Cap (Cr) 10.60 1 Yr Return (%) -14.27% P/E (TTM) 13.25 PB Ratio 1.58
Jagsonpal Pharmaceuticals Ltd Cash Flow
Cash flow data provides a view of how money is generated and spent by Jagsonpal Pharmaceuticals Ltd, across its operating activities, investing activities, and financing activities.
PARTICULARS Operating Activities Mar 2025 55.30
PARTICULARS Investing Activities Mar 2025 -45.15
PARTICULARS Financing Activities Mar 2025 -11.70
PARTICULARS Net Cash Flow Mar 2025 -1.54
Jagsonpal Pharmaceuticals Ltd Shareholding Pattern
This shows the ownership breakdown of Jagsonpal Pharmaceuticals Ltd, highlighting participation from Foreign Institutional Investors (FII), Mutual Funds, Public, Other Institutions, and Promoters.
Promoter 67.54%
Public 30.25%
Other Institutions 0.08%
FII 2.12%
Mutual Funds null%
About Jagsonpal Pharmaceuticals Ltd
Promoted by Rajpal Singh Kochhar in August, 1978, Jagsonpal Pharmaceuticals Limited is engaged in the manufacture and marketing bulk drugs and pharmaceuticals at its plant at Faridabad in Haryana. The Company has adopted the strategy of clubbing all its products in seven groups for effective marketing and reducing costs. Simultaneously, it has geared up to set up an ultra modern multi-purpose basic drugs and formulation plant through its subsidiary, Jagsonpal Exports India Pvt Ltd.The company has a strategic alliance with Fidia Spa, Italy; and B Spofola, Czechoslovakia; to manufacture sophisticated drugs in India. It has tied up with another Israel-based company, Makhteshim Chemical Works, for acquiring the marketing rights of an anti-oxidant product. In 1994, the company has also promoted Aresco Financial Services, a new financial company.The Company's R&D activities have resulted in manufacturing process upgradation, improving packaging, and cost containment. It's R&D activities are geared towards development of new product technologies which can be commercialised in future.It has tied up with Lycored Natural Products Industries (LNP) of Israel, to launch a completely natural Lycopene bioactive product, Lycored, in India and SouthEast Asia.In the fiscal 2001, the company's sales grew by 15% to Rs 136.52 crore and the profit at the net level was up 8% to Rs 10.15 crore. This was achieved against heavy odds, such as, sluggish market trends, lower growth rate of the industry and severe competition from drug majors. However the company has introduced various measures to counter the above factors so as to achieve continued growth and opportunity.The new manufacturing facility at Pantnagar, Uttarakhand started production in April 2009. The Company launched two brands, Divatrone and ProRetro in the market segment, Dydrogesterone, which was earlier dominated by a global pharma Company in August, 2021.On June 27, 2022, Infinity Holdings, an India-focused investment group acquired control over the Company consequent to acquisition of 43.73% of equity capital and became Promoters of the Company. The Company identified several products as part of new launches such as Indocap Gel, Lycored Plus, MemUp, Queezy ER to enhance healthcare professionals' confidence and improve patient outcomes in 2023-24. It acquired the India and Bhutan business of Yash Pharma in June, 2024.
Executive Director & MD
Manish Gupta
Registered office T-210 J, Shahpur Jat, New Delhi, New Delhi, 110049
FAX :91-011-46181100/46109900
Background
Incorporation Year 1978
Face Value ₹2.00
Market Lot 1
FAQs on Jagsonpal Pharmaceuticals Ltd
How to buy Jagsonpal Pharmaceuticals Ltd shares on NSE?
To buy Jagsonpal Pharmaceuticals Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified.
What is the Jagsonpal Pharmaceuticals Ltd share price today?
The Jagsonpal Pharmaceuticals Ltd share price on NSE is ₹201.59 today.
What is the market cap of Jagsonpal Pharmaceuticals Ltd on NSE?
The company has a market capitalization of ₹1346.24.
What is the PE & PB ratio of Jagsonpal Pharmaceuticals Ltd?
PE is 22 and PB is 9.
What is the 52 Week High and Low of Jagsonpal Pharmaceuticals Ltd shares?
Jagsonpal Pharmaceuticals Ltd stock price high: ₹328.04 Jagsonpal Pharmaceuticals Ltd stock price low: ₹192.85.